Home Hemodialysis

Many patients may experience post-dialysis disruption, but their emotional response to adversity depends on whether they feel high or low levels of regret, according to recently published data.

PHILADELPHIA — In a clinical trial, patients placed on home hemodialysis four times a week showed improved outcomes over in-center treatment using the Quanta Dialysis System, according to data presented here at ASN Kidney Week.

Quanta Dialysis Technologies has submitted a 510(k) premarket notification to the FDA for an expanded indication of its dialysis machine to include home hemodialysis.

The FDA has granted clearance to Fresenius Medical Care for its VersiHD with GuideMe Software, a self-guided interface for the company’s VersiHD chronic home hemodialysis system, according to a press release.

KANSAS CITY, Missouri — Although home hemodialysis utilization has increased since the pandemic, uptake still can be improved upon, according to a speaker at the Annual Dialysis Conference.

Patients who underwent home hemodialysis failure had a greater risk of mortality than those who continued home dialysis.

Use of patient navigators in chronic kidney disease and kidney failure correlate with improved outcomes in some settings and patient populations, according to data published in Kidney Medicine.

Compared with other dialysis modalities in the United Kingdom, continuous ambulatory peritoneal dialysis appeared to be less costly between 2018 and 2019, according to data published in Peritoneal Dialysis International.

Compared with patients who continued home hemodialysis treatment, patients who experienced home hemodialysis failure correlated with a “significant” increase in mortality.

Bipartisan legislation was introduced in Congress on Sept. 29 that would fund staff assistance for patients on home dialysis.